Literature DB >> 26039573

Virulence genes and cytokine profile in systemic murine Campylobacter coli infection.

Anja Klančnik1, Maja Šikić Pogačar2, Peter Raspor3, Maja Abram4, Sonja Smole Možina1, Darinka Vučković4.   

Abstract

Campylobacter coli are one of the most common bacteria in bacterial gastroenteritis and acute enterocolitis in humans. However, relatively little is known regarding the mechanisms of pathogenesis and host response to C. coli infections. To investigate the influence of genetic changes, we first used PCR to demonstrate the presence of the known virulence genes cadF, virB11, cdtB, cdtC and ceuE in the clinical isolate C. coli 26536, which was isolated from the liver of infected BALB/c mice. Sequence analyses of the cadF, virB11, cdtB and ceuE genes in C. coli 26536 confirmed the stability in these virulence genes during their transmission through the host. We further investigated C. coli infection for the bacterial clearance from the liver and spleen of infected mice, and for their immune response. C. coli persisted well in both organs, with better survival in the liver. We also determined the levels of several pro-inflammatory cytokines (i.e., interleukin [IL]-6, IL-12, interferon-γ, tumor necrosis factor-α) and the anti-inflammatory cytokine IL-10 in plasma and in liver homogenates from the infected mice, using enzyme-linked immunosorbent assays. The lowest levels among these cytokines were for tumor necrosis factor-α in the plasma and IL-6 in the liver on days 1, 3 and 8 post-infection. The most pronounced production was for IL-10, in both plasma (days 1 and 8 post-infection) and liver (day 8 post-infection), which suggests that it has a role in healing of the organ inflammation. Our findings showed dynamic relationships between pro- and anti-inflammatory cytokines and thus contribute toward clarification of the healing processes involved in the resolution of C. coli infections.

Entities:  

Keywords:  Campylobacter coli; cytokine profile; mouse model; virulence factors

Mesh:

Substances:

Year:  2015        PMID: 26039573      PMCID: PMC4720231          DOI: 10.1080/21505594.2015.1042642

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  52 in total

Review 1.  Current status and challenges of cytokine pharmacology.

Authors:  Z Zídek; P Anzenbacher; E Kmonícková
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

2.  CdtA, CdtB, and CdtC form a tripartite complex that is required for cytolethal distending toxin activity.

Authors:  M Lara-Tejero; J E Galán
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

Review 3.  An overview of methods used to clarify pathogenesis mechanisms of Campylobacter jejuni.

Authors:  N Haddad; C Marce; C Magras; J-M Cappelier
Journal:  J Food Prot       Date:  2010-04       Impact factor: 2.077

4.  Effect of growth phase on the adherence to and invasion of Caco-2 epithelial cells by Campylobacter.

Authors:  M Ganan; G Campos; R Muñoz; A V Carrascosa; S de Pascual-Teresa; A J Martinez-Rodriguez
Journal:  Int J Food Microbiol       Date:  2010-02-23       Impact factor: 5.277

5.  Differences in virulence attributes between cytolethal distending toxin positive and negative Campylobacter jejuni strains.

Authors:  Deepika Jain; Kashi Nath Prasad; Sushmita Sinha; Nuzhat Husain
Journal:  J Med Microbiol       Date:  2008-03       Impact factor: 2.472

6.  Correlation of proinflammatory and anti-inflammatory cytokine levels with histopathological changes in an adult mouse lung model of Campylobacter jejuni infection.

Authors:  Nadia Al-Banna; Raj Raghupathy; M John Albert
Journal:  Clin Vaccine Immunol       Date:  2008-09-30

Review 7.  Host-pathogen interactions in Campylobacter infections: the host perspective.

Authors:  Riny Janssen; Karen A Krogfelt; Shaun A Cawthraw; Wilfrid van Pelt; Jaap A Wagenaar; Robert J Owen
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

Review 8.  Campylobacter jejuni-mediated disease pathogenesis: an update.

Authors:  Matthias Zilbauer; Nick Dorrell; Brendan W Wren; Mona Bajaj-Elliott
Journal:  Trans R Soc Trop Med Hyg       Date:  2007-11-19       Impact factor: 2.184

9.  PCR detection of seven virulence and toxin genes of Campylobacter jejuni and Campylobacter coli isolates from Danish pigs and cattle and cytolethal distending toxin production of the isolates.

Authors:  D D Bang; E Møller Nielsen; F Scheutz; K Pedersen; K Handberg; M Madsen
Journal:  J Appl Microbiol       Date:  2003       Impact factor: 3.772

10.  Dendritic cells from C57BL/6 mice undergo activation and induce Th1-effector cell responses against Campylobacter jejuni.

Authors:  Vijay A K Rathinam; Kathleen A Hoag; Linda S Mansfield
Journal:  Microbes Infect       Date:  2008-08-05       Impact factor: 2.700

View more
  3 in total

1.  Beyond Campylobacter jejuni: understanding Campylobacter coli infections in a systemic model of disease.

Authors:  Lisa M Harrison
Journal:  Virulence       Date:  2015-06-17       Impact factor: 5.882

2.  Temporal induction of pro-inflammatory and regulatory cytokines in human peripheral blood mononuclear cells by Campylobacter jejuni and Campylobacter coli.

Authors:  Eman Hamza; Sonja Kittl; Peter Kuhnert
Journal:  PLoS One       Date:  2017-02-14       Impact factor: 3.240

3.  Effects of Sublethally Injured Campylobacter jejuni in Mice.

Authors:  Gayani Weerasooriya; Andrea R McWhorter; Samiullah Khan; Kapil K Chousalkar
Journal:  Microbiol Spectr       Date:  2022-07-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.